Mechanismen der Kardiotoxizität onkologischer Therapien = Mechanisms of cardiotoxicity of oncological therapies
Onkologische Therapien zeigen am Herz-Kreislauf-System eine Reihe unerwünschter Wirkungen. Insbesondere neuere Therapien sind diesbezüglich unzureichend verstanden, und klinische Daten fehlen bei der Interpretation neuer kardialer Komplikationen.
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | German |
| Published: |
09 October 2020
|
| In: |
Der Internist
Year: 2020, Volume: 61, Issue: 11, Pages: 1132-1139 |
| ISSN: | 1432-1289 |
| DOI: | 10.1007/s00108-020-00881-2 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00108-020-00881-2 Verlag, lizenzpflichtig, Volltext: https://link.springer.com/article/10.1007/s00108-020-00881-2 
|
| Author Notes: | L.H. Lehmann, S. Fröhling |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1915680514 | ||
| 003 | DE-627 | ||
| 005 | 20250716224643.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 250127s2020 xx |||||o 00| ||ger c | ||
| 024 | 7 | |a 10.1007/s00108-020-00881-2 |2 doi | |
| 035 | |a (DE-627)1915680514 | ||
| 035 | |a (DE-599)KXP1915680514 | ||
| 035 | |a (OCoLC)1528017773 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a ger | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Lehmann, Lorenz |d 1980- |e VerfasserIn |0 (DE-588)131855212 |0 (DE-627)515807184 |0 (DE-576)298796104 |4 aut | |
| 245 | 1 | 0 | |a Mechanismen der Kardiotoxizität onkologischer Therapien |b = Mechanisms of cardiotoxicity of oncological therapies |c L.H. Lehmann, S. Fröhling |
| 246 | 3 | 1 | |a Mechanisms of cardiotoxicity of oncological therapies |
| 264 | 1 | |c 09 October 2020 | |
| 300 | |b Illustrationen | ||
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 27.01.2025 | ||
| 520 | |a Onkologische Therapien zeigen am Herz-Kreislauf-System eine Reihe unerwünschter Wirkungen. Insbesondere neuere Therapien sind diesbezüglich unzureichend verstanden, und klinische Daten fehlen bei der Interpretation neuer kardialer Komplikationen. | ||
| 650 | 4 | |a Anthracyclines | |
| 650 | 4 | |a Anthrazykline | |
| 650 | 4 | |a Cardio-oncology | |
| 650 | 4 | |a Doxorubicin | |
| 650 | 4 | |a Heart failure | |
| 650 | 4 | |a Herzinsuffizienz | |
| 650 | 4 | |a Immun-Checkpoint-Inhibitoren | |
| 650 | 4 | |a Immune checkpoint inhibitor | |
| 650 | 4 | |a Kardioonkologie | |
| 700 | 1 | |a Fröhling, Stefan |d 1969- |e VerfasserIn |0 (DE-588)120890046 |0 (DE-627)080950302 |0 (DE-576)188733930 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Der Internist |d Berlin : Springer, 1996 |g 61(2020), 11, Seite 1132-1139 |h Online-Ressource |w (DE-627)253724384 |w (DE-600)1459232-0 |w (DE-576)072373180 |x 1432-1289 |7 nnas |a Mechanismen der Kardiotoxizität onkologischer Therapien = Mechanisms of cardiotoxicity of oncological therapies |
| 773 | 1 | 8 | |g volume:61 |g year:2020 |g number:11 |g pages:1132-1139 |g extent:8 |a Mechanismen der Kardiotoxizität onkologischer Therapien = Mechanisms of cardiotoxicity of oncological therapies |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s00108-020-00881-2 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://link.springer.com/article/10.1007/s00108-020-00881-2 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20250127 | ||
| 993 | |a Article | ||
| 994 | |a 2020 | ||
| 998 | |g 120890046 |a Fröhling, Stefan |m 120890046:Fröhling, Stefan |d 50000 |e 50000PF120890046 |k 0/50000/ |p 2 |y j | ||
| 998 | |g 131855212 |a Lehmann, Lorenz |m 131855212:Lehmann, Lorenz |d 910000 |d 910300 |d 50000 |e 910000PL131855212 |e 910300PL131855212 |e 50000PL131855212 |k 0/910000/ |k 1/910000/910300/ |k 0/50000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1915680514 |e 4656682071 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["ger"],"title":[{"title_sort":"Mechanismen der Kardiotoxizität onkologischer Therapien","subtitle":" = Mechanisms of cardiotoxicity of oncological therapies","title":"Mechanismen der Kardiotoxizität onkologischer Therapien"}],"person":[{"role":"aut","display":"Lehmann, Lorenz","given":"Lorenz","family":"Lehmann"},{"role":"aut","display":"Fröhling, Stefan","given":"Stefan","family":"Fröhling"}],"recId":"1915680514","titleTranslated":[{"translated":"Mechanisms of cardiotoxicity of oncological therapies"}],"origin":[{"dateIssuedDisp":"09 October 2020","dateIssuedKey":"2020"}],"name":{"displayForm":["L.H. Lehmann, S. Fröhling"]},"relHost":[{"type":{"media":"Online-Ressource","bibl":"periodical"},"pubHistory":["Nachgewiesen 37.1996-volume 63, issue 6 (June 2022)"],"recId":"253724384","disp":"Mechanismen der Kardiotoxizität onkologischer Therapien = Mechanisms of cardiotoxicity of oncological therapiesDer Internist","language":["ger"],"physDesc":[{"extent":"Online-Ressource"}],"part":{"volume":"61","text":"61(2020), 11, Seite 1132-1139","year":"2020","pages":"1132-1139","extent":"8","issue":"11"},"id":{"eki":["253724384"],"zdb":["1459232-0"],"issn":["1432-1289"]},"note":["Gesehen am 21.09.2022","Erscheint monatlich","Ungezählte Beil.: Supplement"],"origin":[{"dateIssuedDisp":"[1996?-2022]","publisher":"Springer","publisherPlace":"Berlin ; Heidelberg"}],"title":[{"title_sort":"Internist","subtitle":"Organ des Berufsverbandes Deutscher Internisten, Organ der Deutschen Gesellschaft für Innere Medizin","title":"Der Internist"}]}],"note":["Gesehen am 27.01.2025"],"physDesc":[{"noteIll":"Illustrationen","extent":"8 S."}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"eki":["1915680514"],"doi":["10.1007/s00108-020-00881-2"]}} | ||
| SRT | |a LEHMANNLORMECHANISME0920 | ||